Literature DB >> 24215142

The development of a national children's formulary.

Warren Lenney1.   

Abstract

The British National Formulary has been in existence for over 30 years. The prescribing of medicines for children has been less well organized. Many medicines used in children have never been tested in the appropriate age groups and have been prescribed 'off-label'. This has led to safety issues and concerns that children continued to be treated as second-class citizens. The first attempt at the development of a national formulary specifically for prescribing in children occurred in 1999 with the publication of 'Medicines for Children'. This generated much national and international interest resulting in the government agreeing to fund the development and production of the first British National Formulary for Children in 2005. This article charts the process and progress of the formulary to the present day.
© 2013 The British Pharmacological Society.

Entities:  

Keywords:  Medicines for Children; National Children's Formulary; off-label; unlicensed

Mesh:

Year:  2015        PMID: 24215142      PMCID: PMC4345954          DOI: 10.1111/bcp.12280

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Unlicensed and off label drug use in neonates.

Authors:  S Conroy; J McIntyre; I Choonara
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

2.  Paracetamol prescription by age or by weight?

Authors:  Warren Lenney
Journal:  Arch Dis Child       Date:  2011-12-07       Impact factor: 3.791

3.  Unlicensed and off label drug use in paediatric wards: prospective study.

Authors:  S Turner; A Longworth; A J Nunn; I Choonara
Journal:  BMJ       Date:  1998-01-31

4.  Use of "off-label" and unlicensed drugs in paediatric intensive care unit.

Authors:  S Turner; A Gill; T Nunn; B Hewitt; I Choonara
Journal:  Lancet       Date:  1996-02-24       Impact factor: 79.321

5.  British National Formulary for Children: the risk of inappropriate paracetamol prescribing.

Authors:  Sally Eyers; James Fingleton; Ashley Eastwood; Kyle Perrin; Richard Beasley
Journal:  Arch Dis Child       Date:  2011-10-01       Impact factor: 3.791

  5 in total
  3 in total

1.  Paediatric prescribing: why children are not small adults.

Authors:  Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

Review 2.  The evidence-based choice for antipsychotics in children and adolescents should be guaranteed.

Authors:  Daria Putignano; Antonio Clavenna; Laura Reale; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2019-02-07       Impact factor: 2.953

3.  Development and Evaluation of a Web-Based Paediatric Drug Information System for Germany.

Authors:  Julia Zahn; Stefan Wimmer; Wolfgang Rödle; Irmgard Toni; Brita Sedlmayr; Hans-Ulrich Prokosch; Wolfgang Rascher; Antje Neubert
Journal:  Pharmacy (Basel)       Date:  2021-01-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.